Vetted Data Analysis Professionals

“Senior infrastructure/platform engineer with deep IBM Power/AIX (Power9, VIOS, HMC, LPAR/DLPAR) and PowerHA production ownership at scale (40 frames / ~300 LPARs), including hands-on outage recovery and performance tuning. Also delivers modern DevOps/IaC capabilities—CI/CD for Kubernetes microservices and Terraform-based multi-account AWS (EKS/VPC/IAM/RDS) with drift detection and safe rollout controls.”

“Former corporate retail leader (25 years) who recently launched a boutique consultancy and has already advised ~12 early-stage founders. Specializes in installing disciplined but lightweight operating systems across merchandising, inventory planning, and wholesale readiness—driving outcomes like +53% YTD growth for a D2C/wholesale apparel brand and rebuilding a NYC candy brand’s margin structure ahead of major wholesaler launches in 2026.”

“Transformation and operations leader hired by a Chief Transformation Officer to drive global process and service-experience efficiencies across North America, Europe, and Australia. Led a 25+ member cross-functional team to build a claims transformation portfolio spanning three business segments, delivering $75M in annual net benefit, and is strong in executive alignment, governance, and productivity systems (dashboards, operating cadence, operating models).”

Carrie Vincent

Screened

Executive Design & Strategy Leader specializing in global studio leadership and service innovation

Seattle, WA29y exp

“Operations and consulting leader with ~30 years’ experience scaling and stabilizing creative/consulting organizations, including growing frog’s Seattle office from a 3-person seed team to nearly 60 and serving as interim MD at ustwo. Known for diagnosing friction across people/projects/P&L, implementing operating rhythms and stage-gated delivery systems, and driving profitability improvements through client rate-structure redesign and executive decision-making coaching.”

“Life sciences business development leader with experience as Head of Business Development at Praxis Precision Medicines, leveraging VC relationships to source value-accretive opportunities such as a partnership with Cerebral Therapeutics. Demonstrates a founder-oriented mindset and unusually rigorous biotech opportunity assessment, including nuanced evaluation of mechanism, preclinical data, and compounded biology/technology risk.”